Approval · Notice of Compliance 7677 · 2006
TROSEC: Notice of Compliance 7677
Issued January 10, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7677
- Date
- January 10, 2006
- Company
- Oryx Pharmaceuticals Inc., A Subsidiary Of Filiale D'arrow Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Anticholinergic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TROSEC | 02275066 | Cancelled Post Market |
Medicinal ingredients
- TROSPIUM CHLORIDE 20 MG per TAB